A Phase 2 Open-label Study of RO4929097 in Metastatic Colorectal Cancer.

Trial Profile

A Phase 2 Open-label Study of RO4929097 in Metastatic Colorectal Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2013

At a glance

  • Drugs RG 4733 (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Dec 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Mar 2012 Actual end date (March 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top